Abstract: Since the end of December 2019,corona virus disease 2019(COVID-19)has been spreading globally,bringing great threat to human health.The patients with malignant tumors have low immune function and belong to the high risk susceptible population.Once infected,the disease progresses rapidly.Hepatocellular and pancreatic system tumors are highly invasive,progress rapidly,poor prognosis and high mortality.In the severe epidemic situation,it brings double challenges to both doctor and patient.How to rationally control the patients with hepatobiliary and pancreatic malignancies is particularly important.For patients with severe disease,jaundice or biliary tract infection should take active treatment measures,and patients with stable condition and good physical conditions or postoperative adjuvant treatment can reduce the treatment intensity and time,and delay or even postponed the treatment.The clinicians should choose the individual treatment decision based on the specific situation.

Key words: Corona virus disease 2019(COVID-19), Hepatobiliary and pancreatic cancer, Patient management